Terug
36
17
Dagbereik
€ 5,21
€ 5,22
52-Weeksbereik
€ 3,91
€ 5,22
Volume
200
50D / 200D Gem.
€ 4,40
/
€ 4,41
Vorige Slotkoers
€ 5,08
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -95,1 | 0,2 |
| P/B | 0,7 | 2,9 |
| ROE % | -0,7 | 3,7 |
| Net Margin % | -1,2 | 3,9 |
| Rev Growth 5Y % | 16,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 16,58% annually over 5 years — strong growth
Earnings declined -223,95% over the past year
Debt/Equity of 0,10 — conservative balance sheet
Generating 68,34M in free cash flow
PEG of 0,50 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,54%
Groei
Revenue Growth (5Y)
16,58%
Revenue (1Y)21,12%
Earnings (1Y)-223,95%
FCF Growth (3Y)62,18%
Kwaliteit
Return on Equity
-0,69%
ROIC-0,20%
Net Margin-1,19%
Op. Margin-0,49%
Veiligheid
Debt / Equity
0,10
Current Ratio2,39
Interest Coverage-0,21
Waardering
P/E Ratio
-95,12
Forward P/EN/A
P/B Ratio0,67
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,12% | Revenue Growth (3Y) | 17,06% |
| Earnings Growth (1Y) | -223,95% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,58% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 449,72M | Net Income (TTM) | -5,37M |
| ROE | -0,69% | ROA | -0,51% |
| Gross Margin | 33,49% | Operating Margin | -0,49% |
| Net Margin | -1,19% | Free Cash Flow (TTM) | 68,34M |
| ROIC | -0,20% | FCF Growth (3Y) | 62,18% |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 2,39 |
| Interest Coverage | -0,21 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -95,12 | Forward P/E | N/A |
| P/B Ratio | 0,67 | P/S Ratio | 1,14 |
| PEG Ratio | 0,50 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 13,38% | ||
| Market Cap | 510,76M | Enterprise Value | 512,22M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 449,72M | 371,30M | 328,20M | 293,56M | 243,48M |
| Net Income | -5,37M | 4,33M | -16,84M | -29,89M | 15,68M |
| EPS (Diluted) | -0,05 | 0,04 | -0,16 | -0,26 | 0,13 |
| Gross Profit | 150,62M | 174,41M | 152,65M | 138,06M | 115,41M |
| Operating Income | -2,20M | 7,40M | -2,89M | -2,40M | -5,32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,05B | 963,80M | 945,49M | 1,05B | 991,89M |
| Total Liabilities | 278,80M | 168,69M | 198,62M | 228,98M | 149,87M |
| Shareholders' Equity | 766,65M | 795,11M | 746,87M | 825,86M | 842,02M |
| Total Debt | 77,85M | 49,46M | 69,09M | 77,70M | 40,96M |
| Cash & Equivalents | 76,39M | 80,11M | 58,76M | 71,68M | 85,96M |
| Current Assets | 394,51M | 396,81M | 365,12M | 395,62M | 307,32M |
| Current Liabilities | 165,13M | 111,25M | 114,03M | 141,32M | 105,30M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#515 of 829
Custom
Full Throttle
#135 of 145
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 27, 2026
Ingestapt
Full Throttle
Mar 27, 2026